00000cam 2200000zi 4500 9.965559 CaOODSP 20260910153938 m o d f cr cn |||||||| 260831e202609##onc ob f000 0 eng d 9781100003825 CaOODSP eng rda CaOODSP n-cn--- H164-235/2026E-PDF Guidance on preparing and submitting summary reports for marketed drugs and natural health products. At head of title: Health products [September 2026 edition]. [Ottawa] : Health Canada = Santé Canada, September 2026. ©2026 text txt rdacontent computer c rdamedia online resource cr rdacarrier Title from cover. Issued also in French under title: Ligne directrice sur la préparation et la présentation des rapports de synthèse pour les drogues et les produits de santé naturels commercialisés. Includes bibliographical references (page 32). "This guidance document helps market authorization holders (MAHs) and licence holders prepare and submit annual summary reports for drugs and natural health products, interim summary reports for Natural Health Products or issue-related summary reports for drugs that comply with the following: Food and Drugs Act (FDA); Food and Drug Regulations (FDR) or Natural Health Products Regulations (NHPR)"--Overview, page 1. Canada. Food and Drugs Act. Natural health products Government policy Canada. Pharmaceutical policy Canada. Canada. Health Canada, issuing body. Ligne directrice sur la préparation et la présentation des rapports de synthèse pour les drogues et les produits de santé naturels commercialisés. (CaOODSP)9.965558 Preparing and submitting summary reports for marketed drugs and natural health products [May 23, 2018 edition] (CaOODSP)9.856242 PDF 731 KB https://publications.gc.ca/collections/collection_2026/sc-hc/H164-235-2026-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/preparing-submitting-summary-reports-marketed-drugs-natural-health-products.html 260287